Moderna names manufacturing veteran Juan Andres COO
As seen on the 24/7 Wall St. homepage on October 5, 2026.
Moderna put manufacturing veteran Juan Andres back in an operating seat as Jerh Collins retires, and the market read it as a launch-readiness move: the stock rose 5.71% on Oct. 5. For an $81.1 billion vaccine maker whose next act depends on getting new products out the door, who runs operations is the whole story.
Continue ReadingShow less
Moderna put Juan Andres in the Chief Operating Officer seat on October 5, and the stock rose 5.71% that day. Investors are pricing in the company's ability to get new products manufactured and out the door.
Andres is a manufacturing veteran whose background is grounded in building and delivering at scale. For a vaccine maker whose next chapter rests on launching a pipeline of new products, that expertise at the top of operations carries real weight.
Jerh Collins is retiring from the role, and transitions at the COO level unsettle markets. Investors instead read the choice of Andres as an upgrade in launch readiness.
At Moderna, the path from a promising clinical result to a product that reaches patients runs through manufacturing and logistics. Who holds the COO seat shapes how quickly the next wave of revenue materializes.
Sources
Mentioned: MRNA